What Are Pacemakers?

Pacemakers are implantable electronic devices that deliver controlled electrical impulses to the heart muscle to regulate cardiac rhythm and maintain adequate heart rate in patients whose natural conduction system is impaired. They sit at the intersection of cardiology and biomedical engineering, combining precision pulse generation circuitry with biocompatible enclosures designed to function reliably inside the human body for a decade or more. The first clinical pacemaker implant was performed in 1958, and the device has since evolved from a bulky external unit into a system small enough to be placed entirely within a cardiac chamber without leads.

Pacemakers are classified within the broader category of cardiac implantable electronic devices, which also includes implantable cardioverter-defibrillators and cardiac resynchronization therapy systems. Their engineering design is addressed in published work on implantable medical device development from a biomedical engineering perspective, which traces the engineering decisions that drove miniaturization, biocompatibility, and battery longevity from the 1950s to the present.

Pacing Modes and Device Types

Pacemakers are categorized by chamber configuration and pacing mode using a five-position generic code developed by the North American Society of Pacing and Electrophysiology (NASPE) and the British Pacing and Electrophysiology Group (BPEG). The first three positions describe the chambers paced, the chambers sensed, and the response mode (inhibited, triggered, or both). A single-chamber pacemaker carries one lead placed in either the right atrium or the right ventricle. A dual-chamber device carries two leads, one in each chamber, and coordinates atrioventricular timing to better replicate the natural conduction sequence. Biventricular pacemakers add a third lead on the left ventricular wall and are used specifically for cardiac resynchronization therapy in patients with heart failure and conduction delays.

Lead Systems and Biocompatible Design

Traditional pacemakers deliver their impulses through transvenous leads, insulated wires threaded through the venous system and anchored at the endocardium. The lead tip electrode makes contact with the myocardium, delivering a stimulus and sensing intrinsic electrical activity. Lead design balances low electrical impedance for efficient energy delivery against mechanical flexibility sufficient to withstand millions of cardiac contractions. The pulse generator housing is typically machined titanium, which provides electromagnetic shielding and a hermetic seal protecting the electronics from body fluids. Lithium-iodine batteries have been the dominant power source since the 1970s, valued for their predictable voltage decline, low self-discharge, and typical service life of seven to twelve years. More recently, leadless pacemakers have been introduced; these self-contained capsule-sized devices are delivered via catheter and anchored directly to the right ventricular wall, eliminating the lead-related failure modes that account for a significant fraction of device complications. IEEE Spectrum has covered advances in dissolvable and flexible implant technology that may further reduce implantation burden.

Rate-Adaptive Pacing and Cardiac Resynchronization

Conventional fixed-rate pacing maintains a set lower heart rate limit, but rate-adaptive pacemakers incorporate sensors that adjust pacing rate to physiological demand. Common sensing approaches include piezoelectric accelerometers that detect body movement, minute ventilation sensors that infer respiratory effort from transthoracic impedance, and combinations of both. The fourth position of the NASPE/BPEG code indicates rate modulation capability. Cardiac resynchronization therapy (CRT), delivered by biventricular devices, addresses the dyssynchronous ventricular contraction seen in patients with left bundle branch block; CRT has been shown in clinical trials to reduce hospitalizations and mortality in carefully selected heart failure populations. Nature Biomedical Engineering has published work on next-iteration implantable devices that aim to harvest cardiac mechanical energy to power the device indefinitely, potentially eliminating the need for battery replacement procedures.

Applications

Pacemakers have applications in a range of clinical and engineering areas, including:

• Treatment of symptomatic bradycardia and atrioventricular block in cardiology
• Cardiac resynchronization therapy for heart failure with conduction delays
• Post-surgical cardiac support following open-heart procedures
• Research platforms for studying cardiac electrophysiology
• Development of wireless telemetry and medical implant communication systems